Know Cancer

forgot password

Quality Of Life Outcomes Following Treatment for Esophageal Cancer

18 Years
Not Enrolling
Esophageal Cancer

Thank you

Trial Information

Quality Of Life Outcomes Following Treatment for Esophageal Cancer

In order to determine the impact of esophageal cancer and its treatment on patients' quality
of life over time, this study will prospectively follow a cohort of patients at specified
intervals, evaluating their physical symptoms, physical and social functioning and overall
quality of life. Medical and sociodemographic factors as well as health behaviors that might
be predictive of adaptation will be tested. This is a preliminary investigation and it is
hoped that we will be able to base future research questions on the results of this study.

Inclusion Criteria:

- Age 18 or older

- Diagnosis of esophageal cancer.

- Anticipated to undergo surgical resection (Ivor Lewis, Trans Hiatal, McKeown
procedure) of esophageal cancer. (Group 1 patients only)

- Underwent esophagectomy for esophageal cancer at least 18 months prior to consent,
with no evidence of disease. (Group 2 patients only)

- Ability to speak, read and write English.

Exclusion Criteria:

- Inability to give informed consent.

- Patients anticipated to require a laryngectomy as part of their surgical resection.

Type of Study:


Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

To prospectively evaluate the quality of life of patients before and after esophageal cancer resection.

Outcome Time Frame:

Initial assessment → first post op visit → 6 and 12 months post surgery

Safety Issue:


Principal Investigator

Manjit Bains, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center


United States: Institutional Review Board

Study ID:




Start Date:

August 2003

Completion Date:

June 2013

Related Keywords:

  • Esophageal Cancer
  • Esophageal
  • CancerEsophagus
  • Esophageal Diseases
  • Esophageal Neoplasms



Memorial Sloan Kettering Cancer Center New York, New York  10021